*DSI: Disease Specificity Index for the gene. **DPI: Disease Pleiotropy Index for the gene.
Gene ID filter_list | Gene Symbol filter_list | Disease Name filter_list | Disease Category filter_list | DSI* filter_list | DPI** filter_list |
---|---|---|---|---|---|
NO RESULT FOUND | |||||
113 | ADCY7 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.685 | 0.345 |
113 | ADCY7 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.685 | 0.345 |
375790 | AGRN | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.735 | 0.31 |
375790 | AGRN | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.735 | 0.31 |
302 | ANXA2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.485 | 0.793 |
302 | ANXA2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.485 | 0.793 |
307 | ANXA4 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.636 | 0.448 |
307 | ANXA4 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.636 | 0.448 |
308 | ANXA5 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.49 | 0.69 |
308 | ANXA5 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.49 | 0.69 |
309 | ANXA6 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.569 | 0.724 |
309 | ANXA6 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.569 | 0.724 |
366 | AQP9 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.63 | 0.586 |
366 | AQP9 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.63 | 0.586 |
8623 | ASMTL | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.857 | 0.103 |
8623 | ASMTL | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.857 | 0.103 |
55252 | ASXL2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.72 | 0.379 |
55252 | ASXL2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.72 | 0.379 |
481 | ATP1B1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.69 | 0.345 |
481 | ATP1B1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.69 | 0.345 |
79870 | BAALC | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.696 | 0.241 |
79870 | BAALC | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.696 | 0.241 |
60468 | BACH2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.596 | 0.586 |
60468 | BACH2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.596 | 0.586 |
596 | BCL2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.312 | 0.862 |
596 | BCL2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.312 | 0.862 |
822 | CAPG | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.616 | 0.655 |
822 | CAPG | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.616 | 0.655 |
824 | CAPN2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.636 | 0.586 |
824 | CAPN2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.636 | 0.586 |
840 | CASP7 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.611 | 0.586 |
840 | CASP7 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.611 | 0.586 |
865 | CBFB | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.627 | 0.414 |
865 | CBFB | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.627 | 0.414 |
894 | CCND2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.519 | 0.655 |
894 | CCND2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.519 | 0.655 |
945 | CD33 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.567 | 0.586 |
945 | CD33 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.567 | 0.586 |
960 | CD44 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.389 | 0.862 |
960 | CD44 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.389 | 0.862 |
928 | CD9 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.54 | 0.759 |
928 | CD9 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.54 | 0.759 |
1021 | CDK6 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.508 | 0.69 |
1021 | CDK6 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.508 | 0.69 |
1050 | CEBPA | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.533 | 0.586 |
1050 | CEBPA | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.533 | 0.586 |
1052 | CEBPD | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.6 | 0.69 |
1052 | CEBPD | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.6 | 0.69 |
51510 | CHMP5 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.857 | 0.069 |
51510 | CHMP5 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.857 | 0.069 |
1269 | CNR2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.554 | 0.621 |
1269 | CNR2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.554 | 0.621 |
1387 | CREBBP | Acute myeloid leukemia with t(8;16)(p11;p13) translocation | N/A | 0.451 | 0.862 |
1436 | CSF1R | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.508 | 0.655 |
1436 | CSF1R | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.508 | 0.655 |
1437 | CSF2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.356 | 0.966 |
1437 | CSF2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.356 | 0.966 |
1440 | CSF3 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.421 | 0.828 |
1440 | CSF3 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.421 | 0.828 |
1471 | CST3 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.5 | 0.724 |
1471 | CST3 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.5 | 0.724 |
1495 | CTNNA1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.636 | 0.483 |
1495 | CTNNA1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.636 | 0.483 |
1512 | CTSH | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.663 | 0.517 |
1512 | CTSH | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.663 | 0.517 |
1522 | CTSZ | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.676 | 0.345 |
1522 | CTSZ | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.676 | 0.345 |
1612 | DAPK1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.513 | 0.655 |
1612 | DAPK1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.513 | 0.655 |
1665 | DHX15 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.773 | 0.241 |
1665 | DHX15 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.773 | 0.241 |
1788 | DNMT3A | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.507 | 0.69 |
1788 | DNMT3A | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.507 | 0.69 |
30845 | EHD3 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.743 | 0.138 |
30845 | EHD3 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.743 | 0.138 |
10919 | EHMT2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.659 | 0.621 |
10919 | EHMT2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.659 | 0.621 |
1978 | EIF4EBP1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.529 | 0.793 |
1978 | EIF4EBP1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.529 | 0.793 |
55740 | ENAH | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.773 | 0.172 |
55740 | ENAH | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.773 | 0.172 |
2026 | ENO2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.559 | 0.724 |
2026 | ENO2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.559 | 0.724 |
2078 | ERG | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.511 | 0.69 |
2078 | ERG | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.511 | 0.69 |
355 | FAS | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.393 | 0.862 |
355 | FAS | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.393 | 0.862 |
2274 | FHL2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.588 | 0.517 |
2274 | FHL2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.588 | 0.517 |
2322 | FLT3 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.503 | 0.517 |
2322 | FLT3 | Acute myeloid leukemia, minimal differentiation | N/A | 0.503 | 0.517 |
2322 | FLT3 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.503 | 0.517 |
2308 | FOXO1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.49 | 0.724 |
2308 | FOXO1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.49 | 0.724 |
53826 | FXYD6 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.785 | 0.138 |
53826 | FXYD6 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.785 | 0.138 |
10634 | GAS2L1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.857 | 0.069 |
10634 | GAS2L1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.857 | 0.069 |
2624 | GATA2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.536 | 0.621 |
2624 | GATA2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.536 | 0.621 |
2672 | GFI1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.604 | 0.345 |
2672 | GFI1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.604 | 0.345 |
2969 | GTF2I | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.565 | 0.655 |
2969 | GTF2I | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.565 | 0.655 |
3005 | H1F0 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.707 | 0.483 |
3005 | H1F0 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.707 | 0.483 |
3082 | HGF | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.394 | 0.793 |
3082 | HGF | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.394 | 0.793 |
3006 | HIST1H1C | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.815 | 0.172 |
3006 | HIST1H1C | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.815 | 0.172 |
3205 | HOXA9 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.572 | 0.552 |
3205 | HOXA9 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.572 | 0.552 |
3315 | HSPB1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.468 | 0.69 |
3315 | HSPB1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.468 | 0.69 |
3398 | ID2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.592 | 0.552 |
3398 | ID2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.592 | 0.552 |
3417 | IDH1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.463 | 0.69 |
3417 | IDH1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.463 | 0.69 |
3418 | IDH2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.469 | 0.655 |
3418 | IDH2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.469 | 0.655 |
10437 | IFI30 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.72 | 0.345 |
10437 | IFI30 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.72 | 0.345 |
3717 | JAK2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.43 | 0.69 |
3717 | JAK2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.43 | 0.69 |
7994 | KAT6A | Acute myeloid leukemia with t(8;16)(p11;p13) translocation | N/A | 0.602 | 0.517 |
3815 | KIT | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.394 | 0.759 |
4297 | KMT2A | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.46 | 0.793 |
4297 | KMT2A | Acute myeloid leukemia, 11q23 abnormalities | N/A | 0.46 | 0.793 |
4297 | KMT2A | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.46 | 0.793 |
58508 | KMT2C | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.604 | 0.621 |
58508 | KMT2C | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.604 | 0.621 |
3845 | KRAS | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.35 | 0.724 |
3845 | KRAS | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.35 | 0.724 |
1902 | LPAR1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.586 | 0.552 |
1902 | LPAR1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.586 | 0.552 |
4066 | LYL1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.72 | 0.138 |
4066 | LYL1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.72 | 0.138 |
4233 | MET | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.405 | 0.793 |
4233 | MET | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.405 | 0.793 |
4330 | MN1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.72 | 0.276 |
4330 | MN1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.72 | 0.276 |
4599 | MX1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.63 | 0.621 |
4599 | MX1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.63 | 0.621 |
4609 | MYC | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.382 | 0.724 |
4609 | MYC | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.382 | 0.724 |
4629 | MYH11 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.567 | 0.483 |
4629 | MYH11 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.567 | 0.483 |
4763 | NF1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.458 | 0.724 |
4763 | NF1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.458 | 0.724 |
4869 | NPM1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.496 | 0.69 |
4869 | NPM1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.496 | 0.69 |
4893 | NRAS | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.42 | 0.69 |
4893 | NRAS | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.42 | 0.69 |
4928 | NUP98 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.586 | 0.414 |
4928 | NUP98 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.586 | 0.414 |
5142 | PDE4B | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.609 | 0.517 |
5142 | PDE4B | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.609 | 0.517 |
11040 | PIM2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.656 | 0.448 |
11040 | PIM2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.656 | 0.448 |
5457 | POU4F1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.672 | 0.276 |
5457 | POU4F1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.672 | 0.276 |
11168 | PSIP1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.555 | 0.655 |
11168 | PSIP1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.555 | 0.655 |
5781 | PTPN11 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.429 | 0.828 |
5781 | PTPN11 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.429 | 0.828 |
7837 | PXDN | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.707 | 0.31 |
7837 | PXDN | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.707 | 0.31 |
10125 | RASGRP1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.667 | 0.448 |
10125 | RASGRP1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.667 | 0.448 |
5997 | RGS2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.598 | 0.655 |
5997 | RGS2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.598 | 0.655 |
861 | RUNX1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.467 | 0.69 |
861 | RUNX1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.467 | 0.69 |
862 | RUNX1T1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.567 | 0.759 |
862 | RUNX1T1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.567 | 0.759 |
864 | RUNX3 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.494 | 0.69 |
864 | RUNX3 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.494 | 0.69 |
6281 | S100A10 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.598 | 0.552 |
6281 | S100A10 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.598 | 0.552 |
6279 | S100A8 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.481 | 0.828 |
6279 | S100A8 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.481 | 0.828 |
10801 | SEPT9 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.588 | 0.655 |
10801 | SEPT9 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.588 | 0.655 |
6446 | SGK1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.53 | 0.621 |
6446 | SGK1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.53 | 0.621 |
6678 | SPARC | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.466 | 0.793 |
6678 | SPARC | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.466 | 0.793 |
6688 | SPI1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.676 | 0.483 |
6688 | SPI1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.676 | 0.483 |
81848 | SPRY4 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.602 | 0.552 |
81848 | SPRY4 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.602 | 0.552 |
6774 | STAT3 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.358 | 0.862 |
6774 | STAT3 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.358 | 0.862 |
6840 | SVIL | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.857 | 0.103 |
6840 | SVIL | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.857 | 0.103 |
9145 | SYNGR1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.743 | 0.241 |
9145 | SYNGR1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.743 | 0.241 |
6919 | TCEA2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.799 | 0.138 |
6919 | TCEA2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.799 | 0.138 |
54790 | TET2 | secondary acute myeloid leukemia | N/A | 0.499 | 0.586 |
54790 | TET2 | Acute myeloid leukemia with multilineage dysplasia | N/A | 0.499 | 0.586 |
8743 | TNFSF10 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.44 | 0.828 |
8743 | TNFSF10 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.44 | 0.828 |
7200 | TRH | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.547 | 0.621 |
7200 | TRH | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.547 | 0.621 |
7204 | TRIO | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.636 | 0.517 |
7204 | TRIO | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.636 | 0.517 |
7249 | TSC2 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.463 | 0.69 |
7249 | TSC2 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.463 | 0.69 |
7280 | TUBB2A | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.707 | 0.31 |
7280 | TUBB2A | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.707 | 0.31 |
81552 | VOPP1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.815 | 0.138 |
81552 | VOPP1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.815 | 0.138 |
11326 | VSIG4 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.727 | 0.345 |
11326 | VSIG4 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.727 | 0.345 |
7490 | WT1 | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.444 | 0.69 |
7490 | WT1 | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.444 | 0.69 |
51341 | ZBTB7A | Acute Myeloid Leukemia, M1 | Neoplasms ; | 0.59 | 0.552 |
51341 | ZBTB7A | Acute Myeloid Leukemia (AML-M2) | Neoplasms ; | 0.59 | 0.552 |